It has been reported that Cheng et al. (2021) have developed a novel nanomedicine (CuQDA/IO@HA) containing copper ions and quercetin to specifically target cancer cells via CD44 and induce specific cytotoxicity in breast cancer (BRCA)-mutated cancer cells. This evidence concerns the gene CD44 and cancer.